(CIDRAP News) A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.
In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.
(CIDRAP News) Deliveries of seasonal influenza vaccine have already outpaced the number of doses ever distributed in a single season, officials from the US Centers for Disease Control and Prevention (CDC) said today, but they voiced concerns about a possible mismatch of one of the strains.
(CIDRAP News) – In one of the largest head-to-head studies comparing two different seasonal flu vaccines in a healthy, adult population, those who received trivalent inactivated vaccine (TIV) had fewer medical visits for respiratory illnesses compared to those who received the live attenuated influenza vaccine (LAIV).
(CIDRAP News) Nearly 5 months after its launch, the pandemic H1N1 vaccine still appears to have a safety profile similar to that of seasonal flu vaccines, the US Centers for Disease Control and Prevention (CDC) said in an update yesterday.
(CIDRAP News) The price-tag for federal investments in new flu vaccine technology has been difficult to get a handle on, but yesterday in a review for Congress the Government Accountability Office (GAO) put the number at $2.1 billion since fiscal year 2005.